PHARMA SAMPLE

Pharma margin diagnostic

Synthetic example showing how XZMargin adapts the same profitability and working-capital engine to this business type.

SAMPLE DATA
Revenue analysed₹4.82Crsample period
Contribution₹73.4L15.2% margin
Margin leakage₹8.7Lestimated review opportunity
Cash blocked₹31.6Lslow / excess stock
Expiry-risk stock₹6.8Lbatch-level review
INDUSTRY CONTEXT

What management sees

Manufacturing unitBaddi 18.4% vs Vapi 10.3%
Export marketGCC vs East Africa contribution
Batch / expiryPrioritise stock before expiry
DECISION MODEL

Issue → evidence → ₹ impact → action

XZMargin does not change billing or bookkeeping. It uses available transaction, purchase, stock and direct-cost evidence to prioritise commercial decisions.

If a required cost or dimension is missing, that view should be marked data-dependent instead of inventing a number.

PROFITABILITY VIEW

Where margin is strong or weak

Product / packRevenueMarginAction
Cardio-X 10mg · Pack 30₹82.4L17.8%Healthy
Neurocare 50mg · Pack 10₹64.7L8.1%Review pricing
Onco-A 100mg · Vial₹51.3L5.4%Cost pressure
Respira-D · Pack 20₹43.9L19.6%Push more
ACTION CENTER

Highest-value issues first

synthetic ₹ impact
01

Reprice export orders where packaging + purchase cost moved faster

₹3.2L
02

Review expiry-risk batch B-118 before next purchase cycle

₹2.6L
03

Reduce slow-moving stock at Unit 2

₹4.9L
TRY WITH YOUR DATA

Keep your existing accounting workflow.

Start with CSV/XLSX exports from Tally, BUSY, Excel or another ERP. No migration is required for the first diagnostic.

Create workspaceChoose another industry